Piscataway, NJNCT05033028Now EnrollingIRB Ready

Opioid Addiction Clinical Trial in Piscataway, NJ

Access cutting-edge opioid addiction treatment through this phase 3 clinical trial at a research site in Piscataway. Study-provided care at no cost to qualified participants.

Sponsored by NYU Langone Health

Quick Self-Assessment

See if you qualify for this Piscataway location

Preparing your pre-screening questions…

Expert Care in Piscataway

Access opioid addiction specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related opioid addiction treatment provided free

Apply for This Piscataway Location

Check if you qualify for this opioid addiction clinical trial in Piscataway, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Piscataway

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Piscataway site if eligible
  4. 4Begin participation

About This Opioid Addiction Study in Piscataway

Treatments for opioid addiction exist, but effectiveness is compromised when subjects use illicit opiates during treatment. Reuse rates during treatment can be high, and reducing illicit opiate use during treatment has thus recently become a major NIDA policy goal. The 5-minute battery indicates the numerical probability that a patient will reuse illicit opiates within the next 7-10 days.

Sponsor: NYU Langone Health

Who Can Participate

Inclusion Criteria

Meet DSM-5 criteria for opioid-use disorder (heroin and/or prescription opioids);
Have entered, or expressed a clear intention to enter, an OUD treatment program that prescribes either methadone or buprenorphine
Any gender;
18 years of age and older;
Have used opioids other than as specifically prescribed within thirty days prior to consent;
In good-enough general health;
Capacity to provide written informed consent as assessed by our Subject Comprehension Assessment Tool(subjects lacking the ability to consent will not be enrolled) ;
Able to speak English sufficiently to understand the study procedures and provide written informed consent to participate in the study. Study-Physician Participants.
Licensed MD employed by the respective site, or at a clinical partner of the respective site, where they will act as participants and be part of the treatment team
Currently practicing in the treatment of OUD with either Buprenorphine or Methadone;
Able to speak, read, and write English fluently and to provide informed consent in English Clinician Participants.
Licensed MSW, NP, or MD; who are not part of any treatment team within the study and may be employees of their respective sites or other treatment facilities.
Currently practicing in the treatment of OUD with either Buprenorphine or Methadone;
Able to speak, read, and write English fluently and to provide informed consent in English

Exclusion Criteria

Serious medical, psychiatric or non-opioid substance use disorder that, in the opinion of a study physician, would make study participation hazardous to the participant or compromise study findings or would prevent the participant from completing the study. Examples include: (a) Disabling or terminal medical illness (e.g., uncompensated heart failure, cirrhosis or end-stage liver disease) as assessed by medical history, review of systems, physical exam and/or laboratory assessments;
Severe, untreated or inadequately treated mental disorder (e.g., active psychosis, uncontrolled manic-depressive illness) as assessed by history and/or clinical interview;
Current severe alcohol, benzodiazepine, or other depressant or sedative hypnotic use likely to require a complicated medical detoxification (routine alcohol and sedative detoxifications may be included);
Suicidal or homicidal ideation that requires immediate attention;
Presence of pain of sufficient severity as to require ongoing pain management with opioids;
Pending legal action or other reasons that might prevent an individual from completing the study.
Pregnancy as assessed by urine pregnancy testing
Breastfeeding of infants, as assessed by self-report.
Prisoners, as defined by OHRP, are excluded from participation in the study.
Individuals receiving residential court-ordered substance abuse treatment. Study-Physician Participants.
none Clinician Participants.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Piscataway?

Yes, this clinical trial (NCT05033028) has an active research site in Piscataway, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Opioid Addiction Treatment Options in Piscataway, NJ

If you're searching for opioid addiction treatment options in Piscataway, NJ, this clinical trial (NCT05033028) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Piscataway research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced opioid addiction specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all opioid addiction clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in Piscataway, NJ

See all alzheimers disease clinical trials recruiting in Piscataway — not just this study.

Browse Alzheimers Disease Trials in Piscataway →

Browse More Trials by Condition

Alzheimers Disease TrialsADHD TrialsSubstance Use Disorder TrialsAtopic Dermatitis TrialsInterstitial Cystitis TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in Piscataway?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Piscataway, NJ